Skip to main content

Initiation of buy-back programme

Written by Customer Service on . Posted in Public Companies.

ANNOUNCEMENT NO. 309

15 May 2026

Initiation of buy-back programme

The Board of Directors of ChemoMetec A/S has decided to buy back own shares based on the authorisation granted at the Annual General Meeting on 9 October 2025. The authorisation is valid until the next Annual General Meeting, which will be held on 8 October 2026 and covers up to 10% of the share capital.

At the start of the share buy-back programme, ChemoMetec A/S does not hold any own shares. The purpose of the share buy-back programme is to adjust the company’s capital structure.

The share buy-back programme runs from 18 May 2026 up to and including 8 October 2026.

The share buy-back programme is carried out without the application of the Safe Harbour rules in Article 5 of the Market Abuse Regulation. The buy-back is carried out at market price and in accordance with the authorisation granted by the general meeting and within the framework of the rules of the Market Abuse Regulation.

To ensure that the trades are carried out on arm’s length terms, Danske Bank A/S (lead manager) will be responsible for all trades under the share buy-back programme. Danske Bank A/S has also been given a discretionary mandate to investigate and potentially acquire shares from major shareholders (block trades).

Under this agreement, Danske Bank A/S will make its trading decisions independently of and without the influence of ChemoMetec A/S and within the following framework:

  • A maximum of 500,000 shares may be repurchased, corresponding to 2.9% of the share capital.
  • The maximum consideration that ChemoMetec A/S may pay for shares purchased under the programme is DKK 100 million.

Additional Information

Martin Helbo Behrens, CEO
Tel.: (+45) 35 77 99 49

Kim Nicolajsen, CFO
Tel.: (+45) 35 77 99 49

About ChemoMetec A/S

ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements. ChemoMetec’s instruments are marketed to the pharmaceutical, biotech and agricultural industries worldwide. ChemoMetec’s customers include some of the world’s leading pharmaceutical companies.

ChemoMetec was founded in 1997 and is listed on Nasdaq OMX Copenhagen. For further information, go to www.chemometec.com.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.